Hui Li, Tao Yang, Xinmin Mao
Central Laboratory of Xinjiang Medical University, Urumqi 830011, China.
College of Traditional Medicine, Xinjiang Medical University, Urumqi 830011, China.
Evid Based Complement Alternat Med. 2021 Oct 14;2021:9948609. doi: 10.1155/2021/9948609. eCollection 2021.
Diabetic retinopathy (DR) is one of the main diabetic microvascular complications in clinical practice, which features a complicated mechanism and insignificant efficacy. Therefore, it is urgent to find effective drugs. Xinjiang Nutt is a rare alpine wild plant with unique effects and extremely high medicinal value. Preliminary studies have shown that it can reduce elevated blood sugar, unhealthy lipids, and antioxidants. This study was intended to investigate the protective effect of the effective components of Nutt on the retinopathy of db/db diabetic mice and provide experimental basis for exploring the efficacy of Nutt and the development of new drugs for the treatment of DR.
The db/db diabetic mouse models were used, and the effective components of Nutt were obtained from Nutt using macroporous resin enrichment method after alcohol extraction. These mice were divided into the normal group, model group, and high-dose Coreopsis Nutt groups, the positive drug metformin group, and the metformin and Nutt combination group. After these db/db type 2 diabetes mouse models were intervened for 10 weeks, their weight, blood sugar, glycosylated hemoglobin, serum MDA, SOD, and other indicators of each group were tested, and the expression changes of VEGF, ICAM1, PEDF, Bcl-2 in mouse retina were observed by immunohistochemistry method.
The effective components of Nutt were obtained using macroporous resin enrichment method after alcohol extraction, which were mainly comprised of chlorogenic acid, flavone mariside, mariside, dicaffeoyl quinic acid, and flavone oxanine, with a total content of 532.82 mg/g, and the total flavonoid content of 330 mg/g. The effective components of Nutt significantly reduced blood sugar and glycosylated hemoglobin and improved oxidative stress levels in db/db diabetic mice. Meanwhile, they reduced the expression of VEGF and ICAM1 in retinopathy and increased the expression of Bcl-2 and PEDF. The combination of Nutt and metformin has the most significant effect.
Nutt can prevent and treat early diabetic retinopathy by affecting the expression of retinopathy-related factors.
糖尿病视网膜病变(DR)是临床常见的糖尿病微血管并发症之一,其发病机制复杂,治疗效果欠佳,因此亟待寻找有效的治疗药物。新疆雪莲是一种珍稀的高山野生植物,具有独特功效和极高的药用价值。前期研究表明,其具有降低血糖、血脂及抗氧化作用。本研究旨在探讨雪莲有效成分对db/db糖尿病小鼠视网膜病变的保护作用,为探索雪莲的药效及研发治疗DR的新药提供实验依据。
采用db/db糖尿病小鼠模型,通过乙醇提取后用大孔树脂富集法从雪莲中获取有效成分。将小鼠分为正常组、模型组、高剂量雪莲组、阳性药物二甲双胍组以及二甲双胍与雪莲联合组。对db/db 2型糖尿病小鼠模型干预10周后,检测各组小鼠体重、血糖、糖化血红蛋白、血清丙二醛(MDA)、超氧化物歧化酶(SOD)等指标,并采用免疫组化法观察小鼠视网膜中血管内皮生长因子(VEGF)、细胞间黏附分子1(ICAM1)、色素上皮衍生因子(PEDF)、Bcl-2的表达变化。
经乙醇提取后用大孔树脂富集法从雪莲中获取的有效成分,主要含绿原酸、黄酮马里苷、马里苷、二咖啡酰奎宁酸、黄酮奥昔宁,总含量为532.82mg/g,总黄酮含量为330mg/g。雪莲有效成分可显著降低db/db糖尿病小鼠的血糖和糖化血红蛋白水平,改善氧化应激状态,同时降低视网膜病变中VEGF和ICAM1的表达,增加Bcl-2和PEDF的表达。雪莲与二甲双胍联合使用效果最为显著。
雪莲可通过影响视网膜病变相关因子的表达防治早期糖尿病视网膜病变。